Yasmeen Nkrumah-Elie, Ph.D., Global Director of External Research at ChromaDex, Honored with the Trailblazing Woman Award by Radicle Science and Council for Responsible Nutrition (CRN) [Ya...
ChromaDex Corporation (CDXC)
NASDAQ:AMEX Investor Relations:
investors.chromadex.com
Company Research
Source: Yahoo! Finance
"I am deeply honored to receive the Trailblazing Woman Award," said Dr. Nkrumah-Elie, "and I am moved by the collective force of inspiring women leading within our dietary supplement industry who continue to push the boundaries of what's possible—as my fellow finalists demonstrate. I am grateful for the opportunity to be a part of an industry dedicated to advancing wellness and improving global health." The Trailblazing Woman Award honors women who have made remarkable contributions to the dietary supplement and functional food industry through leadership, innovation, and mentorship. Dr. Nkrumah-Elie was selected for her extraordinary commitment to advancing science, promoting diversity, and mentoring the next generation of female leaders. In addition to her leadership role at ChromaDex, Dr. Nkrumah-Elie is a member of CRN's Senior Scientific Advisory Council and actively contributes to several industry organizations, including Women In Nutraceuticals (WIN) and the American Socie
Show less
Read more
Impact Snapshot
Event Time:
CDXC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CDXC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CDXC alerts
High impacting ChromaDex Corporation news events
Weekly update
A roundup of the hottest topics
CDXC
News
- ChromaDex Co. (NASDAQ: CDXC) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- What Makes ChromaDex (CDXC) a Strong Momentum Stock: Buy Now? [Yahoo! Finance]Yahoo! Finance
- 5 Stocks With Recent Price Strength to Tap Wall Street Rally [Yahoo! Finance]Yahoo! Finance
- ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide [Yahoo! Finance]Yahoo! Finance
- ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics NationwideBusiness Wire
CDXC
Earnings
- 10/31/24 - Beat
CDXC
Sec Filings
- 11/8/24 - Form 3
- 10/31/24 - Form 8-K
- 10/31/24 - Form 10-Q
- CDXC's page on the SEC website